ONeil Trader

Growth, momentum, small-cap, mid-cap
ONeil Trader
Growth, momentum, small-cap, mid-cap
Contributor since: 2012
Aquinox Is Down, But Not Out
The Long Case For Otonomy
The Long Case For Celldex
Why Endo Is A Buy
LGI Homes: What To Expect In 2016
Depomed: The Long Case Strengthens
Time To Buy Alimera?
Is XenoPort Up For Sale?
Supernus: Strong Growth And M&A Rumors
Horizon Pharma: Business As Usual
Vanda: The Long Case Strengthens
With Horizon Out Of The Way, Depomed Is A Bargain